FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new urea-substituted imidazoquinolines of the formula (1):
wherein R, R1, R2 and n have values given in the description, and to pharmaceutical preparations based on these compounds. Proposed compounds possess effect of immunomodulators initiating biosynthesis of different cytokines. Also, invention relates to methods for treatment of different states, among them viral diseases and neoplastic pathologies.
EFFECT: improved method for induction, valuable properties of compounds.
47 cl, 11 tbl, 142 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMIDO-SUBSTITUTED IMIDAZOQUINOLINES | 2000 |
|
RU2295343C2 |
| IMIDAZOQUINOLINES, PHARMACEUTICAL PREPARATION AND METHOD FOR INDUCTION OF CYTOKINE BIOSYNTHESIS BASED ON THEREOF | 2000 |
|
RU2248975C2 |
| ARYLETHER-SUBSTITUTED IMIDAZOQUINOLINES, PHARMACEUTICAL COMPOSITIONS BASED ON THE SAME, METHODS FOR TREATMENT OF VIRAL DISEASES BASED ON THE SAME AND METHODS FOR TREATMENT OF TUMOR DISEASE BASED ON THE SAME | 2001 |
|
RU2308456C2 |
| THIOESTER-SUBSTITUTED IMIDAZOQUINOLINES | 2001 |
|
RU2315049C2 |
| SUBSTITUTED IMIDAZOPYRIDINES | 2001 |
|
RU2294934C2 |
| N-{2-[4-AMINO-2-(ETHOXYMETHYL)-1H-IMIDAZO-[4,5-c]-QUINOLIN-1-YL]-1,1-DIMETHYLETHYL}-METHANESULFONAMIDE AND PHARMACEUTICAL COMPOSITON BASED ON SAID COMPOUND | 2004 |
|
RU2374246C2 |
| UREA-SUBSTITUTED IMIDAZOQUINOLINE ETHERS | 2001 |
|
RU2302418C2 |
| PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND | 2021 |
|
RU2819346C1 |
| METHOD OF SYNTHESIS OF IMIDAZO-(4,5-B)-QUINOLINYLHYDROXYALKANOIC ACID AMIDES OR THEIR PHARMACEUTICALLY USED SALTS | 1990 |
|
RU2041210C1 |
| TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2697090C1 |
